cellular
lipid
homeostasi
maintain
intric
link
array
anabol
catabol
pathway
upon
flaviviru
infect
significantli
alter
one
hand
virus
coopt
lipid
metabol
pathway
gener
atp
facilit
replic
synthes
membran
compon
gener
replic
site
hand
recent
evid
suggest
counter
strategi
employ
host
cell
activ
modul
sever
network
respons
infect
enhanc
interferon
signal
thu
creat
antivir
environ
review
discuss
recent
data
mechan
alter
lipid
metabol
pathway
infect
flavivirus
focu
cholesterol
fatti
acid
biosynthesi
manipul
invad
virus
support
replic
also
modul
host
immun
system
mean
fight
infect
metabol
reprogram
immun
cell
recurr
phenomenon
expos
proinflammatori
stimul
form
pathogen
cytokin
macrophag
dendrit
cell
particular
wellequip
sens
respond
impend
danger
pathogen
thu
establish
frontlin
host
defens
recent
studi
highlight
extraordinari
contribut
multipl
host
metabol
pathway
confer
toward
abil
innat
immun
cell
respond
infect
surprisingli
pathway
function
erad
infect
often
rewir
invad
pathogen
virus
known
induc
aerob
glycolysi
akin
warburg
effect
recent
perturb
lipid
metabol
pathway
also
report
sever
class
pathogen
intracellular
lipid
homeostasi
achiev
balanc
biosynthet
transport
degrad
process
current
evid
increasingli
point
toward
intric
relationship
host
lipid
metabol
intracellular
pathogen
includ
bacteria
virus
parasit
mechanist
detail
yet
unravel
hypothes
pathogen
account
limit
genom
size
coopt
host
metabol
network
meet
energi
demand
procur
precursor
anabol
process
includ
replic
intracellular
transport
addit
virus
alter
lipid
metabol
facilit
amplif
evad
host
immun
respons
decidedli
observ
case
posit
strand
rna
viru
infect
dengu
west
nile
hepat
c
sever
coronavirus
mark
alter
cholesterol
fatti
acid
biosynthesi
occur
upon
infect
accompani
appear
distinct
compart
believ
replic
site
despit
divers
genom
organ
mani
virus
share
certain
salient
featur
primari
depend
host
factor
undergo
replic
assembl
intracellular
transport
releas
intracellular
life
cycl
posit
strand
rna
virus
larg
confin
cytosol
within
surfac
virusinduc
organellelik
structur
regard
replic
compart
notwithstand
differ
transmiss
host
cell
tropism
pathogenesi
virus
employ
similar
strategi
replic
assembl
often
accompani
reorgan
host
secretori
pathway
replic
site
serv
multipl
purpos
function
concert
fashion
facilit
effici
viru
propag
primarili
offer
spatial
segreg
differ
step
intracellular
life
cycl
rna
translat
replic
packag
viral
genom
virion
assembl
viral
replic
compart
also
enabl
high
local
concentr
necessari
componentsboth
viral
hostin
physic
constrain
space
ensur
effici
rna
amplif
equal
import
featur
replic
site
limit
exposur
viral
rna
hostil
cytoplasm
environ
contain
cellular
nucleas
sensor
innat
immun
surveil
degrad
dsrna
replic
intermedi
minim
protect
membranedelimit
compart
although
lipid
metabol
receiv
particular
attent
gramneg
bacteri
infect
sever
recent
report
highlight
function
viral
infect
analog
lipopolysaccharid
lp
mediat
downregul
sterol
synthesi
case
viral
infect
limit
cholesterol
biosynthesi
human
macrophag
fibroblast
via
genet
knockdown
sterol
regulatori
elementbind
protein
sterolregulatori
elementbind
protein
srebp
discuss
later
section
report
spontan
engag
type
ifn
signal
restrict
infect
initi
antivir
immun
thu
display
clear
link
intracellular
cholesterol
biosynthesi
way
induct
cholesterol
synthesi
would
allow
subvers
host
immun
respons
facilit
viral
multipl
advent
omicsbas
studi
increasingli
becom
obviou
virus
induc
largescal
alter
host
cellular
metabol
among
exampl
induct
fatti
acid
synthesi
hepat
c
viru
hcv
human
hepatocyt
util
cellular
lipid
store
hepatocyt
dengu
viru
effect
event
experiment
demonstr
genet
pharmacolog
inhibit
lipid
biosynthet
pathway
attenu
viral
pathogenesi
viral
adapt
strategi
effect
increas
avail
energi
viru
replic
assembl
provid
specif
compon
progeni
particl
creat
replic
site
suppress
antivir
signal
cascad
report
highlight
intric
link
virus
lipid
metabol
follow
section
discuss
emerg
data
fatti
acid
cholesterol
biosynthet
pathway
upregul
certain
virus
facilit
infect
fatti
acid
synthas
fasn
intracellular
content
fatti
acid
cholesterol
contribut
fuel
storag
well
sourc
compon
necessari
increas
membran
product
core
reaction
fatti
acid
synthesi
catalyz
fasn
start
acetyl
coa
malonyl
coa
synthes
palmit
sever
differ
fate
includ
elong
long
chain
fatti
acid
use
membran
product
storag
lipid
droplet
ld
form
triacylglycerol
esterifi
cholesterol
ld
storag
organel
consist
triacylglycerol
steryl
ester
function
inert
storag
depot
excess
cellular
lipid
abund
size
ld
could
indic
increas
fatti
acid
synthesi
might
pois
cell
rapid
membran
gener
need
also
maintain
energi
reserv
accord
cellular
state
correspond
energi
demand
fatti
acid
undergo
gener
acetyl
coa
nadh
molecul
mitochondri
matrix
atp
product
via
oxid
phosphoryl
virus
induc
requir
avail
fatti
acid
sever
stage
lifecycleeith
supplement
energi
requir
anabol
process
gener
viral
replic
compart
notabl
observ
infect
posit
strand
rna
virus
primarili
due
process
replicationconfin
cytoplasmwher
virus
alter
host
intracellular
lipid
composit
creat
benefici
environ
phenomenon
exemplifi
hcv
aspect
viral
lifecycl
includ
entri
replic
assembl
releas
host
lipid
associ
hcv
requir
low
densiti
lipoprotein
receptor
cofactor
entri
target
cell
replic
occur
membran
weblik
compart
refer
doubl
membran
vesicl
assembl
use
ld
platform
gener
replic
site
hcv
trigger
synthesi
fatti
acid
cholesterol
ld
anoth
member
flavivirida
famili
dengu
also
report
induc
product
fatti
acid
fasn
identifi
target
sirna
screen
necessari
factor
effici
dengu
viru
replic
drug
inhibit
fasn
activ
result
signific
attenu
viru
replic
infect
dengu
viru
affect
fasn
express
level
rather
redistribut
virustrigg
structur
refer
convolut
membran
phenomenon
appear
member
gtpase
famili
typic
resid
er
ld
upon
infect
dengu
found
interact
allow
recruit
fasn
viral
replic
site
thu
promot
fatti
acid
biosynthesi
increas
local
concentr
inhibit
fasn
activ
similar
effect
mosquito
cell
loss
infecti
progeni
virion
product
reductas
ratelimit
enzym
cholesterol
biosynthesi
regul
via
neg
feedback
mechan
mediat
product
mevalon
pathway
mammalian
cell
hmgcr
activ
suppress
cholesterol
import
receptormedi
endocytosi
low
densiti
lipoprotein
dengu
infect
inhibit
phosphoryl
hmgcr
inactiv
site
gener
cholesterolrich
environ
process
corrobor
inactiv
ampk
subsequ
increas
hmgcr
activ
respect
comparison
west
nile
viru
infect
direct
impact
intracellular
cholesterol
distribut
infect
accompani
redirect
cholesterol
plasma
membran
viru
replic
site
mammalian
cell
cholesterol
homeostasi
tightli
regul
feedback
mechan
via
transcript
factor
sens
intracellular
cholesterol
level
transcript
factor
term
srebp
associ
tightli
sterolsens
srebp
cleavageactiv
protein
scap
within
er
membran
via
addit
interact
erresid
protein
insig
function
inhibitor
srebp
scap
addit
role
chaperon
mediat
transport
srebpscap
complex
golgi
network
srebp
proteolyt
cleav
two
resid
golgi
proteas
releas
transcript
activ
fragment
srebp
membran
releas
form
srebp
transport
nucleu
activ
transcript
target
gene
requir
cholesterol
fatti
acid
biosynthesi
includ
hmgcr
fasn
respect
cholesterol
level
high
scap
bind
cholesterol
er
promot
associ
insig
retain
complex
within
er
thu
reduc
synthesi
cholesterol
convers
cholesterol
level
low
bind
scap
insig
disrupt
cholesterol
synthesi
initi
author
studi
postul
deenrich
cholesterol
site
harbor
sensori
molecul
scapsrebpinsig
complex
result
activ
signal
pathway
enabl
host
cell
increas
cholesterol
level
accommod
prolifer
intracellular
membran
lipid
droplet
multifunct
organel
present
organ
bacteria
eukaryot
structur
particularli
abund
mammalian
adipocyt
insect
fat
bodi
cell
ld
mainli
compos
phospholipid
monolay
structur
protein
perilipin
involv
ld
biogenesi
degrad
despit
previou
notion
rather
static
role
ld
mainten
lipid
homeostasi
recent
becom
evid
ld
also
present
immun
cell
neutrophil
macrophag
regul
inflammatori
infecti
process
upon
stimul
differ
challeng
display
increas
abund
therebi
serv
reliabl
marker
immun
cell
activ
autophagi
depend
degrad
ld
report
dengu
viru
infect
human
hepatocyt
similar
activ
autophagi
pathway
recent
describ
zika
viru
infect
well
data
accept
queu
public
support
drastic
upregul
ld
consumpt
induct
autophagi
upon
dengu
zika
viru
infect
pathway
appear
oper
ancient
ubiquit
protein
depend
manner
dictat
ubiquityl
statu
unmodifi
enabl
dispers
ld
underw
lipophagi
upon
infect
virustrigg
pathway
essenti
assembl
product
newli
synthes
progeni
virion
press
current
consensu
therefor
support
model
mobil
ld
combin
increas
synthesi
fatti
acid
cholesterol
provid
provir
environ
product
progeni
virion
figur
interdepend
innat
immun
signal
process
regul
sterol
fatti
acid
metabol
increasingli
consolid
emerg
data
role
product
inflammatori
mediat
report
sever
group
interferon
ifn
modul
express
multitud
ifnstimul
gene
includ
viperin
observ
highli
upregul
respons
bacteri
lp
doublestrand
dna
rna
analog
also
possess
antivir
activ
rang
virus
includ
hcv
dengu
viru
similar
vein
inhibit
cholesterol
biosynthesi
also
exert
antivir
effect
srebp
involv
coordin
regul
sterol
fatti
acid
biosynthesi
pathway
ifn
effect
inhibit
mrna
protein
level
interestingli
wnvinduc
redistribut
cellular
cholesterol
found
downregul
ifnstimul
jakstat
antivir
signal
respons
infect
potenti
remov
cholesterol
usual
microenviron
recent
evid
suggest
alter
cellular
lipid
metabol
direct
role
host
defens
posit
regul
type
ifnmedi
antivir
respons
exampl
activ
type
ifn
signal
induc
upregul
inhibit
cholesterol
synthesi
order
creat
hostil
cellular
environ
virus
intracellular
pathogen
known
stimul
de
novo
lipid
cholesterol
biosynthesi
ensur
surviv
accordingli
repress
anabol
pathway
inhibit
evolut
intracellular
infect
activ
type
interferon
receptor
correl
inhibit
cholesterol
biosynthesi
howev
repress
lipid
metabol
manner
accompani
increas
influx
environment
lipid
maintain
intracellular
lipid
cholesterol
normal
level
thu
type
ifn
signal
reprogram
cellular
lipid
metabol
function
limit
lipid
avail
pathogen
therefor
remain
unclear
whether
ifni
link
repress
cholesterol
biosynthesi
context
intracellular
infect
meant
limit
nutrient
avail
pathogen
serv
differ
purpos
scap
protein
act
sterolsens
element
well
chaperon
associ
immatur
srebp
transcript
factor
er
membran
knock
knock
scap
macrophag
srebp
activ
lower
well
express
gene
involv
lipid
metabol
anticip
de
novo
synthesi
cholesterol
fatti
acid
went
absenc
scap
total
intracellular
lipid
level
remain
unchang
loss
scap
also
correl
heighten
resist
viral
infect
vitro
vivo
model
confirm
function
equival
activ
type
interferon
pathway
inhibit
lipid
metabol
cultur
medium
supernat
scap
macrophag
cultur
enough
markedli
increas
resist
viral
challeng
suppli
wildtyp
bmdm
suggest
higher
type
interferonmedi
viral
resist
causal
effect
secret
effector
molecul
interferonbeta
light
qpcr
analysi
reveal
scap
bmdm
alveolar
macrophag
extract
scap
mice
constitut
express
higher
level
interferonstimul
gene
isg
compar
wildtyp
macrophag
final
block
interferon
alphabeta
receptor
ifnar
enough
restor
interferon
isg
express
back
normal
level
well
lose
resist
viral
infect
data
strongli
suggest
absenc
scap
activ
spontan
trigger
type
interferon
product
translat
constitut
state
higher
resist
viral
infect
macrophag
suggest
higher
type
interferon
respons
specif
caus
inhibit
cholesterol
metabol
support
hypothesi
cell
immun
nonimmun
defici
mevalon
pathway
show
constitut
exacerb
type
interferon
respons
also
addit
free
cholesterol
cell
cell
genet
impair
cholesterol
metabol
caus
exagger
type
interferon
respons
decreas
basal
level
stimul
interferon
gene
sting
er
resid
kinas
activ
interferon
regulatori
factor
phosphoryl
tank
bind
sting
kinas
activ
stimul
cyclic
dinucleotid
synthes
cyclic
gmpamp
synthas
cga
cga
sting
phosphoryl
exist
higher
basal
level
cell
compar
wildtyp
cell
addit
knock
either
cga
sting
enough
drastic
lower
presenc
cell
also
knockdown
cga
sting
cell
caus
express
isg
decreas
level
similar
wildtyp
cell
addit
free
cholesterol
cell
significantli
decreas
block
ifnar
effect
level
reinforc
idea
cholesterol
directli
influenc
stingmedi
activ
data
support
model
lack
cholesterol
cell
make
sting
sensit
cyclic
dinucleotid
upregul
signal
axi
ultim
increas
express
isg
confer
intrins
proinflammatori
phenotyp
cholesteroldefici
cell
admittedli
experi
use
howev
conclus
may
well
relev
viru
infect
repress
cholesterol
biosynthet
pathway
inhibitor
hmgcr
common
treatment
cardiovascular
diseas
clinic
success
inhibitor
human
disord
provid
strong
support
target
lipid
metabol
effect
human
therapi
elucid
specif
alter
incur
upon
viru
infect
would
allow
novel
therapeut
approach
emerg
target
inhibit
metabol
pathway
ifn
viral
infect
often
result
induct
macrophagesan
antivir
effector
broadli
inhibit
mani
envelop
virus
interf
membran
fusion
whether
addit
impact
activ
interferon
signal
pathway
seen
futur
studi
differ
strategi
employ
interfer
viru
infect
includ
involv
lipid
util
notwithstand
tempt
specul
drug
alreadi
clinic
use
cholesterol
fatti
acid
metabol
pathway
might
repurpos
boost
antivir
immun
provid
resist
infect
jp
ss
discuss
wrote
manuscript
